View in EDS

Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.

Saved in:
Bibliographic Details
Title: Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.
Authors: Adenis A; Institut du Cancer de Montpellier and IRCM, Université Montpellier, Montpellier, France., Kulkarni AS; Merck & Co, Inc, Kenilworth, NJ., Girotto GC; Hospital de Base de São José do Rio Preto, São José do Rio Preto, Brazil., de la Fouchardiere C; Centre Léon-Bérard, Lyon, France., Senellart H; Centre Rene Gauducheau ICO, Saint-Herblain, France., van Laarhoven HWM; Department of Medical Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands., Mansoor W; Christie NHS Foundation Trust, Manchester, United Kingdom., Al-Rajabi R; University of Kansas Cancer Center, Kansas City, KS., Norquist J; Merck & Co, Inc, Kenilworth, NJ., Amonkar M; Merck & Co, Inc, Kenilworth, NJ., Suryawanshi S; Merck & Co, Inc, Kenilworth, NJ., Bhagia P; Merck & Co, Inc, Kenilworth, NJ., Metges JP; Centre Hospitalier Régional Universitaire de Brest-Hôpital Morvan, Arpego Network, Brest, France.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Feb 01; Vol. 40 (4), pp. 382-391. Date of Electronic Publication: 2021 Nov 03.
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34730989
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Adenis+A%22">Adenis A</searchLink>; Institut du Cancer de Montpellier and IRCM, Université Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Kulkarni+AS%22">Kulkarni AS</searchLink>; Merck & Co, Inc, Kenilworth, NJ.<br /><searchLink fieldCode="AU" term="%22Girotto+GC%22">Girotto GC</searchLink>; Hospital de Base de São José do Rio Preto, São José do Rio Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22de+la+Fouchardiere+C%22">de la Fouchardiere C</searchLink>; Centre Léon-Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Senellart+H%22">Senellart H</searchLink>; Centre Rene Gauducheau ICO, Saint-Herblain, France.<br /><searchLink fieldCode="AU" term="%22van+Laarhoven+HWM%22">van Laarhoven HWM</searchLink>; Department of Medical Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mansoor+W%22">Mansoor W</searchLink>; Christie NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Al-Rajabi+R%22">Al-Rajabi R</searchLink>; University of Kansas Cancer Center, Kansas City, KS.<br /><searchLink fieldCode="AU" term="%22Norquist+J%22">Norquist J</searchLink>; Merck & Co, Inc, Kenilworth, NJ.<br /><searchLink fieldCode="AU" term="%22Amonkar+M%22">Amonkar M</searchLink>; Merck & Co, Inc, Kenilworth, NJ.<br /><searchLink fieldCode="AU" term="%22Suryawanshi+S%22">Suryawanshi S</searchLink>; Merck & Co, Inc, Kenilworth, NJ.<br /><searchLink fieldCode="AU" term="%22Bhagia+P%22">Bhagia P</searchLink>; Merck & Co, Inc, Kenilworth, NJ.<br /><searchLink fieldCode="AU" term="%22Metges+JP%22">Metges JP</searchLink>; Centre Hospitalier Régional Universitaire de Brest-Hôpital Morvan, Arpego Network, Brest, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2022 Feb 01; Vol. 40 (4), pp. 382-391. <i>Date of Electronic Publication: </i>2021 Nov 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34730989
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.21.00601
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 382
    Titles:
      – TitleFull: Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Adenis A
      – PersonEntity:
          Name:
            NameFull: Kulkarni AS
      – PersonEntity:
          Name:
            NameFull: Girotto GC
      – PersonEntity:
          Name:
            NameFull: de la Fouchardiere C
      – PersonEntity:
          Name:
            NameFull: Senellart H
      – PersonEntity:
          Name:
            NameFull: van Laarhoven HWM
      – PersonEntity:
          Name:
            NameFull: Mansoor W
      – PersonEntity:
          Name:
            NameFull: Al-Rajabi R
      – PersonEntity:
          Name:
            NameFull: Norquist J
      – PersonEntity:
          Name:
            NameFull: Amonkar M
      – PersonEntity:
          Name:
            NameFull: Suryawanshi S
      – PersonEntity:
          Name:
            NameFull: Bhagia P
      – PersonEntity:
          Name:
            NameFull: Metges JP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2022 Feb 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1